Reuters logo
1 年前
BRIEF-Lilly, Adocia announce Positive topline results from a Phase 1b study of Lispro U100
2016年4月27日 / 下午4点11分 / 1 年前

BRIEF-Lilly, Adocia announce Positive topline results from a Phase 1b study of Lispro U100

1 分钟阅读

April 27 (Reuters) - Eli Lilly And Co

* Adocia and lilly announce positive topline results from a phase 1b study of repeated administration of ultra-rapid Biochaperone Lispro U100 in people with type 2 Diabetes

* Both biochaperone Lispro and Humalog were similarly well tolerated throughout each 14-day period Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below